U.S. Mortgage REITs Stock News

NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Is Opera (OPRA) Pricing Look Interesting After Strong Three Year Share Price Performance?

If you are wondering whether Opera's share price really reflects what the business is worth, you are not alone. This article is written with that exact question in mind. Over the short term the stock has seen mixed moves, with a 0.1% decline over the last 7 days, a 16.2% gain over 30 days, a 6.0% return year to date, an 11.3% decline over 1 year, and a 102.9% gain over 3 years, compared to a 57.8% return over 5 years. Recently, investors have been reacting to a series of Opera-focused...
NYSE:BABA
NYSE:BABAMultiline Retail

Alibaba Qwen Lead Puts AI Growth And Security Risks In Focus

Alibaba Group Holding's Qwen large language model has become the most deployed self hosted model, surpassing Meta's Llama. The company is expanding its global cloud and AI footprint, including a hyperscale computing center in Shanghai and a leading role in Saudi Arabia's data center build out. Alibaba has also disclosed a security incident involving AI driven unauthorized cryptocurrency mining, highlighting new operational risks. For investors watching NYSE:BABA, these AI and cloud...
NYSE:UTZ
NYSE:UTZFood

Utz Brands Debuts Protein Snacks As Share Price Trails Analyst Valuation

Utz Brands (NYSE:UTZ) presented new protein-enriched snacks and globally inspired flavors at Natural Products Expo West. The lineup includes Boulder Canyon Agave Sriracha kettle chips and a high protein snack range with gluten free, non GMO, and kosher options. The launch targets growing interest in snacks that combine higher protein content with bolder, globally influenced taste profiles. For investors watching NYSE:UTZ, the new products come at a time when the share price is around $7.52,...
NYSE:AORT
NYSE:AORTMedical Equipment

Assessing Artivion (AORT) Valuation After Positive Analyst Views On Aortic Pipeline And NEXUS Trial Results

Recent analyst reports on Artivion (AORT) have zeroed in on the company’s aortic disease pipeline, with particular attention on the NEXUS stent graft system and its one year trial results, which show strong sealing and low complication rates. See our latest analysis for Artivion. Artivion’s share price has eased back recently, with a 30 day share price return of 8.23% and a 90 day share price return of 20.07% from a last close of US$36.35. However, the 1 year total shareholder return of...
NYSE:TMHC
NYSE:TMHCConsumer Durables

Taylor Morrison Home (TMHC) Valuation Check After Recent Share Price Weakness

Recent share performance and business snapshot Taylor Morrison Home (TMHC) has drawn investor attention after a recent stretch of weaker share performance, including negative returns over the past week, month and past 3 months, despite a small positive move year to date. The US homebuilder and land developer reported annual revenue of US$8.1b and net income of US$782.5m, giving investors a sense of its current earnings base as they weigh the recent pullback in the share price. See our latest...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna Valuation Questioned As mRNA Guidance And Flu Review Shift

A U.S. health advisory committee is reconsidering its previous position against recommending mRNA vaccines. This review comes shortly after the FDA reversed its initial refusal to review Moderna's mRNA based flu vaccine application. The developments directly relate to Moderna's mRNA vaccine portfolio and potential demand for its products. For you as an investor following NasdaqGS:MRNA, this is a core business story rather than a side issue. Moderna is primarily focused on mRNA based...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

How IRS Solar Tax-Credit Clarity May Reshape Array Technologies’ (ARRY) Utility-Scale Demand Narrative

In the past few days, Cantor Fitzgerald reiterated its positive rating on Array Technologies after the IRS confirmed that solar projects starting before July 4, 2026, can qualify for the clean electricity production credit. This clarified timeline for tax incentives could encourage developers to bring forward utility-scale solar projects, potentially strengthening Array’s order visibility and demand pipeline. We’ll now explore how the clarified IRS tax-credit timing could influence Array...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro’s New Debt Deal To Fund Digital IP Might Change The Case For Investing In Hasbro (HAS)

Hasbro, Inc. recently completed a US$399.4 million offering of 4.650% senior unsecured notes due March 12, 2031, to refinance older debt and support its shift toward a digital-first, intellectual property-focused business model. This combination of strong earnings led by Magic: The Gathering and proactive balance sheet management highlights how Hasbro is reshaping itself around higher-margin gaming and entertainment assets. We’ll now examine how Hasbro’s debt refinancing to support its...
NYSE:ELF
NYSE:ELFPersonal Products

A Look At E.l.f. Beauty (ELF) Valuation After Piper Sandler Flags Stalling Demand And Sector Weakness

Recent commentary from Piper Sandler flagged stalling consumer demand for e.l.f. Beauty (ELF), with flat February sales, pricing related volume pressure, delayed spring launches, and sector wide concerns weighing on sentiment, even though management kept guidance steady. See our latest analysis for e.l.f. Beauty. At a share price of $79.95, e.l.f. Beauty has seen short term momentum cool after recent pullbacks linked to sector wide worries and flat February demand, while its 1 year total...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth Adds Chip Leader As Mine To Magnet Plans Advance

USA Rare Earth (NasdaqGM:USAR) has appointed semiconductor industry leader Dr. Thomas Caulfield to its Board of Directors. Caulfield, known for his leadership role at GlobalFoundries, joins as the company progresses its Round Top project consolidation. The appointment follows a major government backed funding package tied to building a fully integrated mine to magnet platform in the U.S. USA Rare Earth is working to build a fully integrated domestic supply chain for critical minerals and...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Assessing Liquidia (LQDA) Valuation After Strong Earnings And YUTREPIA Driven Momentum

Liquidia (LQDA) is back on investor radar after its March 5 earnings, where fourth quarter results showed sharply higher revenue and a swing to net income, helped largely by sales of its lead therapy YUTREPIA. See our latest analysis for Liquidia. At a recent share price of US$38.56, Liquidia has seen a 22.8% year to date share price return and a very large 5 year total shareholder return. The 7 day share price return of 12.16% contrasts with a 9.06% 30 day share price decline, suggesting...
NYSE:HUBB
NYSE:HUBBElectrical

Is Hubbell (HUBB) Pricing Look Stretched After Strong Multi Year Share Gains?

Wondering if Hubbell at around US$477.97 is priced for perfection or still leaves room on the table? This article walks through the numbers so you can judge whether the current tag feels stretched or reasonable. The stock has seen a 2.6% decline over the past week and a 5.6% decline over the last 30 days, while still sitting on a 44.6% 1 year return and a 172.8% return over 5 years. That mix of recent pullback and longer term strength raises fair questions about where value stands...
NYSE:HOG
NYSE:HOGAuto

Harley-Davidson Insider Buying Sparks Fresh Look At Value And Risks

Harley-Davidson CEO and a company director recently purchased additional NYSE:HOG shares. Director Lori Flees made a sizeable insider purchase, increasing her personal stake in the company. These transactions add a fresh data point on insider sentiment at a time when the share price is around $18.2. For investors watching Harley-Davidson, the insider buying comes after a tough stretch for NYSE:HOG, with the stock down 6.5% over the past week and 9.6% over the past month. Returns are also...
NYSE:USFD
NYSE:USFDConsumer Retailing

A Look At US Foods Holding (USFD) Valuation After Its Recent Share Price Momentum

Why US Foods Holding (USFD) is on investors’ radar today US Foods Holding (USFD) has drawn investor attention after a steady run in recent months, inviting a closer look at how its share performance and fundamentals line up for long term holders. See our latest analysis for US Foods Holding. At a share price of $91.34, US Foods Holding has seen an emerging upward trend, with a 90 day share price return of 18.79% and a 1 year total shareholder return of 40.05%, suggesting recent momentum...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

C.H. Robinson’s 100 Trillion Data Points Reframe Its AI Advantage

C.H. Robinson Worldwide (NasdaqGS:CHRW) has publicly detailed the scale of its proprietary logistics dataset, which now feeds over 100 trillion real world data points into its Lean AI system. The expanded AI platform coordinates hundreds of AI agents that support millions of shipping decisions across global freight and logistics operations. The company reports measurable benefits for customers, including faster time to market and more consistent pickup performance. C.H. Robinson is putting...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Is It Time To Revisit Coupang (CPNG) After Recent Share Price Weakness

If you are looking at Coupang and wondering whether the current share price reflects its true worth, you are not alone. Many investors are asking the same question. Coupang's share price closed at US$18.77 most recently, with returns of a 1.7% decline over the last 7 days, a 1.2% gain over 30 days, a 19.7% decline year to date and a 15.7% decline over 1 year, while the 3 year return sits at 45.4% and the 5 year return at a 56.6% decline. Recent coverage around Coupang has focused on its...
NYSE:OKE
NYSE:OKEOil and Gas

Is It Time To Reconsider ONEOK (OKE) After Recent Midstream Valuation Debate?

If you are wondering whether ONEOK is fairly priced at its recent levels, you are not alone. This article focuses squarely on what you are getting for the price you pay. ONEOK's share price closed at US$85.76, with returns of 1.2% over 7 days, 3.2% over 30 days, 15.4% year to date and a 2.6% decline over the past year, while the 3 year and 5 year returns sit at 64.8% and 126.1% respectively. Recent news around ONEOK has largely centred on its position in the US energy infrastructure space...
NYSE:MMS
NYSE:MMSProfessional Services

A Look At Maximus (MMS) Valuation After Recent Share Price Moves

Maximus stock performance snapshot after recent moves Maximus (MMS) has drawn fresh attention after recent share price moves, with the stock last closing at $73.75. Investors are weighing this level against recent returns and the company’s government services footprint. See our latest analysis for Maximus. That recent 0.37% one-day share price gain comes after a 14.71% decline in the year to date, while the one-year total shareholder return of 12.62% signals that momentum has cooled recently...
NYSE:PSTG
NYSE:PSTGTech

Everpure Expands Enterprise Data Cloud With ActiveCluster File Data Mobility

Everpure (NYSE:PSTG) has launched ActiveCluster for file, extending its data mobility and availability capabilities across entire storage fleets. The new product targets large-scale, unstructured data across distributed environments, aimed at enterprises running AI and cloud workloads. ActiveCluster for file is designed to support policy-based data movement and high availability without requiring hardware upgrades or downtime. For investors watching Everpure at a share price of $62.09, this...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Shopify (SHOP) Valuation Check After Mixed Returns And High P/E Expectations

What Shopify’s Recent Returns Tell You Right Now Shopify (NasdaqGS:SHOP) has seen mixed share performance recently, with a small 1 day gain of 0.1%, a flat past week, a roughly 9.4% rise over the past month, and a 21.4% decline over the past 3 months. See our latest analysis for Shopify. Looking beyond the recent pullback, Shopify’s 1 year total shareholder return of 34.2% and 3 year total shareholder return of roughly 3x highlight how past gains contrast with the weaker short term share...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music Group (WMG) Valuation Check After New Multi Year JPMorgan Credit Agreement

Warner Music Group (WMG) is back on investors’ radar after its subsidiary WMG Acquisition Corp entered a new multi year credit agreement with JPMorgan Chase, refinancing and consolidating existing debt facilities. See our latest analysis for Warner Music Group. That refinancing news lands after a mixed run for investors, with a 1 day share price return of 0.90%, a 30 day share price decline of 8.61%, and a 1 year total shareholder return decline of 17.16%, suggesting momentum has faded...
NYSEAM:UMAC
NYSEAM:UMACElectronic

Unusual Machines (UMAC) Is Up 35.1% After Revenue Doubled And Losses Narrowed In 2025 Results – Has The Bull Case Changed?

In early March 2026, Unusual Machines, Inc. reported that full-year 2025 sales rose to US$11.2 million from US$5.57 million, while its net loss narrowed to US$19.19 million from US$31.98 million and basic loss per share from continuing operations improved to US$0.74 from US$3.84. The company’s earnings update highlighted rapid scaling of NDAA-compliant drone component production, supported by onshoring initiatives and expansion into U.S.-based motor and headset manufacturing. Next, we’ll...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Valuation Check After Barclays Conference Selloff And ACA Marketplace Concerns

Centene (CNC) is back in focus after its Barclays Healthcare Conference appearance, where management discussed Affordable Care Act headwinds, enrollment declines, expiring premium subsidies, and lower 2026 revenue guidance, along with reaffirmed earnings targets. See our latest analysis for Centene. The conference commentary and reduced 2026 revenue outlook have come on top of already weak share price momentum, with a 7 day share price return of 20.29% decline and a 1 year total shareholder...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

Is It Too Late To Consider Capricor Therapeutics (CAPR) After Strong Multi Year Share Gains?

Wondering whether Capricor Therapeutics at around US$33.57 is still offering value or has already priced in the story? This article will walk you through what the numbers are actually saying about the stock. The share price has been volatile, with returns of 31.6% over the past week, 33.3% over the past month, 18.6% year to date, and 156.8% over the last year, alongside a very large 3 year gain and a more than 5x gain over 5 years. Recent interest in Capricor Therapeutics has been shaped by...